Non-Wearable Audiovisual Distraction for Children's Medical Anxiety in the ED
Effectiveness of Non-Wearable Immersive Audiovisual Distraction in Alleviating Pediatric Anxiety in Emergency Department: A Stratified Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
Pediatric emergency department (ED) visits often cause significant anxiety and stress for young patients due to unfamiliar environments and invasive medical procedures. Non-pharmacological interventions, such as distraction, are vital for reducing pediatric anxiety and improving procedural outcomes. This study evaluates the effectiveness of a non-wearable, immersive audiovisual distraction system (LG StanbyME display) in alleviating pediatric anxiety during emergency department care, compared to standard care. The main questions it aims to answer are: Does non-wearable audiovisual distraction reduce anxiety levels in pediatric emergency patients compared to standard care? Does the intervention improve physiological indicators of distress, such as Heart Rate Variability (HRV)? Participants will: Be randomly assigned to either the non-wearable audiovisual distraction group or the routine care group. Undergo continuous physiological monitoring (HRV) and clinical anxiety assessment (mYPAS-SF) during their ED visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
Study Completion
Last participant's last visit for all outcomes
September 30, 2027
August 12, 2026
July 1, 2026
12 months
August 2, 2026
August 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in Heart Rate Variability High-Frequency Power (HF-HRV)
Continuous measurement of parasympathetic autonomic activity evaluated via HF power in normalized units (nu) or $ms\^2$
Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).
Changes in Heart Rate Variability LF/HF Ratio
Autonomic nervous system balance assessed via the ratio of Low-Frequency to High-Frequency power.
Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).
Changes in Heart Rate Variability RMSSD
Short-term parasympathetic modulation evaluated via Root Mean Square of Successive Differences (RMSSD) in milliseconds (ms).
Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).
Secondary Outcomes (1)
Pediatric Observational Anxiety Score (mYPAS-SF)
Assessed at baseline (pre-procedure) and immediately post-procedure.
Study Arms (2)
Audiovisual Distraction Group
EXPERIMENTALPediatric patients receive non-wearable immersive audiovisual distraction via a mobile display (LG StanbyME presenting low-stimulation, guided soothing videos and simple interactive games) during emergency department procedures.
Routine Care Group
ACTIVE COMPARATORPediatric patients receive standard emergency department care without additional digital audiovisual distraction devices.
Interventions
Implementation of a non-wearable mobile display system (LG StanbyME) providing gentle, low-stimulation audiovisual distraction and digital companionship to alleviate pediatric procedural anxiety.
Standard pediatric emergency department care according to clinical guidelines without digital distraction devices.
Eligibility Criteria
You may qualify if:
- Pediatric patients aged 6 to 12 years presenting to the Emergency Department.
- Requiring invasive medical procedures (e.g., blood sampling, intravenous line insertion, or laceration repair/suturing).
- Patient and legal guardian/parent willing and able to provide informed assent/consent and comply with study protocols.
You may not qualify if:
- Patients with severe developmental delay, cognitive impairment, or neurological disorders affecting communication or behavioral assessment.
- Patients with severe visual or hearing impairment that prevents interaction with the non-wearable display system.
- Hemodynamically unstable patients or those requiring immediate life-saving resuscitation.
- Patients with severe upper body or facial injuries that prevent the placement or operation of continuous ECG recorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital Yunlin Branch
Douliu, Yunlin County, 640203, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nai-Yun Chang, MD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2026
First Posted
August 12, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
August 12, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will become available starting 6 months after publication of the primary manuscript and will remain available for up to 3 years
- Access Criteria
- Data will be made available to qualified academic researchers for non-commercial scientific research. Requesters must submit a formal research proposal, sign a Data Use Agreement (DUA) to ensure participant confidentiality, and obtain approval from the Principal Investigator (Dr. Nai-Yun Chang)
De-identified individual participant data, including demographic characteristics (age, sex), baseline and post-procedural mYPAS-SF scores, and time-domain/frequency-domain Heart Rate Variability (HRV) parameters (HF, LF/HF ratio, RMSSD), will be shared with qualified researchers upon reasonable request.